Featured Research

from universities, journals, and other organizations

New Technique Identifies M. Tuberculosis Genes

Date:
September 29, 1999
Source:
Washington University In St. Louis
Summary:
Josephine Clark-Curtiss, Ph.D., research associate professor of biology at Washington University in St. Louis, and her colleagues have recently identified 15 M. tuberculosis genes that are expressed only when the bacteria are growing in the immune system's prime gatekeeper, a disease-fighting cell called a macrophage.

For most of this century, tuberculosis, or TB, has not been considered a major disease in the United States. In the late '80s, after a century of steady decline, the number of cases of TB in the United States began to increase due to increases in immigrants from countries where TB is prevalent, homeless people in crowded conditions, the elderly and AIDS patients. Although the increase in cases has been reversed in the last several years, more than 18,000 cases of TB were reported in the United States in 1998. Worldwide, TB remains a serious health problem. The World Health Organization has estimated that one-third of the world's population is infected with Mycobacterium tuberculosis, the bacterium that causes TB.

United States researchers have picked up their efforts over the past decade. One, Josephine Clark-Curtiss, Ph.D., research associate professor of biology at Washington University in St. Louis, and her colleagues have recently identified 15 M. tuberculosis genes that are expressed only when the bacteria are growing in the immune system's prime gatekeeper, a disease-fighting cell called a macrophage.

Using an elaborate new technique that is widely applicable to a host of different research situations, James Graham, Ph.D., a post-doctoral researcher in Clark-Curtiss' lab, captured DNA complementary to messenger RNA (called cDNA) of genes active in human macrophages, cells that engulf and degrade pathogenic bacteria, rendering them harmless.

But in the case of M. tuberculosis, the killer bacteria have found a way, once inside the macrophage, to prevent the development of a macrophage compartment known as the phagolysosome. This key compartment produces a number of enzymes that puts the coup de grace on M.tuberculosis.

Clark-Curtiss believes the 15 genes isolated in her laboratory play important roles in the pathogen's metabolism, propagation and self-protection once in the immune system environment. Defining the specific roles of the genes could lead to drugs that target certain of the genes or even a vaccine for the disease that afflicted 6.7 million people worldwide in 1998, killing an estimated 2.4 million, according to the National Academy of Sciences.

"We're interested in genes expressed in the macrophage because we suspect these are vital in keeping the pathogen alive and destructive in the human body," says Clark-Curtiss. "The technique used allows us to study genes at different times after the mycobacteria have been introduced into macrophages. This is important because there really should be some chronology at work--genes expressed right after entering the macrophage, then some even later, and perhaps some that are involved in destroying the macrophage.

"Our next step is to construct mutant mycobacteria by inactivating these genes and infecting macrophages with the mutant strains to see which genes are critical to survival."

Clark-Curtiss published her results in the September, 1999 issue of the Proceedings of the National Academy of Sciences. Her research was sponsored by the National Institutes of Health.

The technique, called SCOTS--for selected capture of transcribed sequences--captures cDNA molecules derived from M. tuberculosis bacteria from a mixture of cDNA molecules from both the macrophages and the bacteria. Put simply, the method captures the desired cDNA molecules while discarding the unwanted ones. This is achieved by hybridization between the cDNA molecules from M. tuberculosis with chromosomal DNA from the bacteria. The hybrids are removed from the reaction mixture by magnets and the desired cDNA molecules are amplified by a widely used technique called PCR (polymerase chain reaction). In the case of the Clark-Curtiss laboratory, she and her colleagues wanted to compare M. tuberculosis cDNA grown in broth culture to that found in M. tuberculosis cDNA from infected macrophages. The technique was able to locate cDNA molecules common to both environments, but it also captured the tiny fraction of the organism's cDNA molecules that is active, or expressed, while the bacteria are in the macrophages. Magnetism, in the form of protein-coated magnetic beads, plays a key role. The beads bind the hybridized M. tuberculosis chromosomal DNA and cDNA molecules, allowing the researchers to eliminate a large portion of non-essential DNA.

The technique was developed James Graham, Ph.D., as an improvement on a cDNA subtractive hybridization technique that had been developed by Georg Plum, Ph.D., when he was a post-doctoral researcher in Clark-Curtiss' laboratory.

"We figured that there are many genes expressed in both conditions, but what we are really interested in is those genes that are expressed by M. tuberculosis when they are in the macrophages, but not expressed in broth culture," says Clark-Curtiss.

Clark-Curtiss says that two of the genes found indicate that M. tuberculosis, like many other bacteria, have a two-component regulatory system that helps them first interact with their environment, then turn on certain genes to thrive in the environment.

Other genes identified are similar to genes of other pathogenic bacteria that have been implicated as important in the virulence of those organisms. Still other genes that Graham and Clark-Curtiss identified by SCOTS have been hypothesized to be important for M. tuberculosis to grow in macrophages. But this is the first experimental evidence supporting these hypotheses.

"It's been difficult to make much progress in understanding M. tuberculosis because M. tuberculosis grows very slowly and special laboratory facilities are required because of the infectiousness of the bacteria," says Clark-Curtiss.

"Moreover, until very recently, there were no methods available to construct specific mutant strains of M. tuberculosis. The SCOTS technique allows us to compare gene expression in M. tuberculosis in response to different environments without having to first inactivate individual genes to determine the importance of each gene to growth in a particular environment.

"This technique is very useful, not just for what we're doing, but for many different situations where you want to compare gene expression in two different environments."


Story Source:

The above story is based on materials provided by Washington University In St. Louis. Note: Materials may be edited for content and length.


Cite This Page:

Washington University In St. Louis. "New Technique Identifies M. Tuberculosis Genes." ScienceDaily. ScienceDaily, 29 September 1999. <www.sciencedaily.com/releases/1999/09/990929021334.htm>.
Washington University In St. Louis. (1999, September 29). New Technique Identifies M. Tuberculosis Genes. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/1999/09/990929021334.htm
Washington University In St. Louis. "New Technique Identifies M. Tuberculosis Genes." ScienceDaily. www.sciencedaily.com/releases/1999/09/990929021334.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins